Protai
PrivateLast Round
Seed
Mar 15, 2023
Total Funding Raised
$20M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Protai operates in Healthcare & Life Sciences and is based in Givatayim. Its latest recorded funding round was a Seed round in March 2023.
Protai is a biotechnology company that has developed an end-to-end AI-based platform that comprehensively maps the course of disease on the protein level, enhancing the ability to observe cellular function and improve the way new drugs are discovered.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Protai Comparables
Compare Protai with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Foreseen Biotechnology | 86% | |
| ProFound Therapeutics | 86% | |
| Promise Bio | 84% |
For institutional investors. Book with your work email.
Protai Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 15, 2023 | ||||
| Seed | Jan 5, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Protai Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Maj Invest Equity A/S | Seed |
| Grove Ventures | Seed |
| Pitango Venture Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 162% MoM, reaching 2.7K.
- Oct 23, 2025
Attending ACR Convergence 2025 to expand into Immunology & Inflammation.
For institutional investors. Book with your work email.
Protai Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Protai's valuation, stock price, and market status.
Is Protai a public or private company?
Protai is a private company.
What is the current stock price of Protai?
Protai is a private company, so its shares have no public market price. Caplight tracks Protai's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Protai worth (valuation)?
Valuation information for Protai is not publicly available.
Can I buy Protai stock?
Protai shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Protai's last funding round?
Protai's most recent funding round was Seed on March 15, 2023.
Who are the main investors in Protai?
Key investors in Protai include Grove Ventures, Pitango Venture Capital.
Will Protai IPO soon?
No public IPO plans have been announced for Protai.
How can I track Protai secondary market activity?
Caplight tracks bids, offers, and trades in Protai's shares on secondary markets.